01 April 2011: Basic Research
Protective effect of bilberry (Vaccinium myrtillus ) against doxorubicin-induced oxidative cardiotoxicity in rats
Osama M. Ashour ABCDEF , Ahmed A. Elberry ABCDEF , Abdulrahman Alahdal E , Ameen M. Al Mohamadi E , Ayman A. Nagy BD , Ashraf B. Abdel-Naim ABCDEF , Essam A. Abdel-Sattar BD , Ahmed M. Mohamadin BD
DOI: 10.12659/MSM.881711
Med Sci Monit 2011; 17(4): BR110-115
Background
Doxorubicin (DOX) is an anthracycline antibiotic used widely in treatment of various malignancies, including acute leukemias, malignant lymphomas, and a variety of solid tumors. However, the occurrence of cardiotoxicity as a major side effect limits its use [1,2]. Although numerous mechanisms have been proposed, most studies implicate increased oxidative stress [3–5]. The idea that reactive oxygen species (ROS) plays a role is supported by the findings that treatment of animals with a variety of antioxidants protects against DOX-induced cardiotoxicity [6,7].
Blueberries belong to the genus Vaccinium, a widespread genus with over 200 species. The prominent species are the North-American highbush (
Material and Methods
DOX was obtained as doxorubicin hydrochloride (2 mg/ml) from EBWE Pharma, A-4866 Unterach, Austria. Bilberry (
Male Wistar rats, weighing 250–300 g, were obtained from the animal facility of King Fahd Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. They were used in the study according to the guidelines of the Biochemical and Research Ethics Committee at King Abdulaziz University. Animals were housed in a well-ventilated, temperature-controlled room at 22±3°C with a 12 h light-dark cycle. They were provided with a balanced commercial diet and tap water. All experimental procedures were performed between 8–10 a.m. and care was taken to avoid stressful conditions.
Rats were randomly divided into 4 groups (12 animals in each group). Group I received carboxymethylcellulose (CMC; 0.5%) (1 ml/200 g body weight/day) orally for 10 consecutive days. Group II received bilberry alone suspended in 0.5% CMC (100 mg/kg; orally once daily for 10 consecutive days). The dose of bilberry was chosen according to pilot experiments conducted by our research group. Group III received CMC orally for 10 consecutive days and a single dose of DOX (15 mg/kg, i.p.) on day 7 [15]. Group IV received both bilberry and DOX in the previously mentioned doses; bilberry was administered for 10 consecutive days and DOX was administered once on day 7.
Twenty-four hours after the last bilberry or CMC treatment (day 11), rats were anesthetized with thiopentone (35 mg/kg; i.p.) and subjected to ECG recording. Blood samples (2–3 ml each) were collected by orbital puncture and were centrifuged for 10 minutes at 3000
ECG was recorded in thiopentone anesthetized rats using the Bioscience ECG recorder (Bioscience, Washington, USA). Needle electrodes were inserted under the skin for the limb lead at position II. Paper speed was 50 mm/sec and the voltage was 1 mV/cm. Noise was minimized by a digital filter.
Reduced glutathione (GSH) content was determined according to the method of Adams et al. [16], and oxidized glutathione (GSSG) level was assessed according to the method of Hissin and Hilf [17] (values are expressed as nmol/mg protein). Lipid peroxidation was determined by measuring thiobarbituric acid reactive substances (TBARS) in tissue homogenates referring to the malondialdehyde (MDA) standard calibration curve according to the method of Uchiyama and Mihara [18] (values are expressed as nmol/g protein). Catalase (CAT) activity was determined according to the method described by Aebi [19] based on determination of the H2O2 decomposition rate at 240 nm (values are expressed as U/mg protein). Superoxide dismutase (SOD) activity was determined according to the method of Sun et al. [20] based on inhibition of nitroblue-tetrazolium reduction by the xanthine-xanthine oxidase system as a superoxide generator (values are expressed as U/mg protein). Glutathione peroxidase (GSH-Px) activity was assessed spectrophotometrically according to the method of Paglia and Valentine [21] (values are expressed as U/mg protein). Myeloperoxidase (MPO) activity was determined by the method of Wei and Frenkel [22] based on using 4-aminoantipyrine/phenol solution as the substrate for MPO-mediated oxidation by H2O2 and recording the changes in absorbance at 510 nm (values are expressed as mU/g protein). Protein carbonyl content (PCC) was determined spectrophotometrically by a method based on the reaction of the carbonyl group with 2,4-dinitrophenylhydrazine to form 2,4-dinitrophenylhydrazone [23] (values are expressed as nanomoles carbonyl/mg protein). The protein content of cardiac tissue homogenates was determined by the Lowry protein assay, using bovine serum albumin as the standard [24].
Creatine phosphokinase (CPK), creatine kinase isoenzyme-MB (CK-MB) and lactate dehydrogenase (LDH) activities were determined according to standard methods, using diagnostic kits from BioSystems S.A. (Barcelona, Spain). Assessment of serum troponin I was carried out by enzyme-linked immunosorbent assay (ELISA) using a kit purchased from DRG International Inc. (Mountainside, NJ, USA).
Hearts were cut at 0.5 μm, mounted on slides, stained with hematoxylin and eosin (H&E) and examined under light microscope (Olympus BX-50 Olympus Corporation, Tokyo, Japan).
Results are expressed as means ±SEM. Assessment of these results was performed using one-way analysis of variance (ANOVA), followed by Tukey-Kramer test for multiple comparisons using GraphPad InStat software, Version 4 (GraphPad Software Inc, La Jolla, CA, USA). The statistical significance was accepted at a level of
Results
ECG tracing showed normal cardiac activity in all rats in the control and bilberry groups, with a mean heart rate of 366±12 and 360±15 beat/min, respectively. Rats in the DOX-only treated group showed bradycardia (254±14 beat/min), ST segment depression and prolongation of both ST and QT intervals. Such ECG abnormalities were clearly improved in the bilberry+DOX group, as evidenced by normalization of heart rate, ST segment, and both ST and QT intervals (Table 1 and Figure 1).
Cardiac content of GSH was significantly reduced in the DOX-only treated group as compared with the control group. Animals in the bilberry+DOX group showed significantly higher levels of GSH as compared to DOX-treated animals. However, GSH level in the bilberry+DOX group was still significantly lower than in the control group. Cardiac levels of GSSG, MDA and protein carbonyl contents were increased significantly in the DOX-only treated group compared with the control group. Bilberry pretreatment significantly guarded against elevations in the latter parameters. Although not normalized, GSSG and MDA levels were significantly lower than the corresponding values in the DOX group. In addition, premedication with bilberry restored the DOX-elevated PCC to the control value (Table 2).
Administration of DOX to rats significantly reduced the cardiac activities of CAT, SOD, and GSH-Px as compared to the control group. The drop in CAT activity caused by DOX treatment was not influenced by bilberry pretreatment, while the activities of SOD and GSH-Px in the bilberry+DOX group were significantly restored to near control values (Table 3). Assessment of MPO activity in cardiac tissues indicated a significant increase in the DOX-only treated group. Pretreatment with bilberry exerted a significant reduction compared to DOX-only treated group, and still significantly higher than the control group (Table 3).
The serum markers indicating myocardial injury (LDH, CPK, CK-MB and troponin I) were significantly elevated in the DOX-only treated group compared with the control and bilberry-only treated group. Pretreatment with bilberry in the bilberry+DOX group significantly reduced their levels as compared with the DOX-only treated group, but were not restored to their corresponding control values (Figure 2).
Hearts from control and bilberry groups showed normal cell distribution and myocardium architecture (Figure 3A, B). Hearts from DOX-only treated rats revealed severe vacuolar degeneration and interstitial edema (Figure 3C). These pathological alterations were markedly ameliorated in animals from the bilberry+DOX group, with mild congestion and some interstitial edema (Figure 3D).
Discussion
Despite the development of several antitumor drugs, DOX continues to be an effective and widely used broad spectrum chemotherapeutic agent; however, its use is limited because of its serious dose-dependent cardiotoxicity [25]. Previous studies have suggested that the generation of free radicals and depletion of endogenous antioxidants induced by DOX are involved in the mechanism of DOX-induced cardiotoxicity [3,26,27]. Inhibiting generation of ROS by antioxidants, as well as the iron chelating agent dexrazoxane, have been shown to ameliorate DOX cardiotoxicity [28]. The present study was designed to investigate the potential protective effects of bilberry extract against DOX-induced cardiotoxicity in rats.
ECG tracing of rats in the DOX group showed bradycardia, ST segment depression and prolongation of both ST and QT intervals, which reflected arrhythmias, conduction abnormalities and attenuation of left ventricular function. Similar changes have been reported by other investigators [15,29–31]. These ECG changes were ameliorated in the bilberry+DOX group, indicating the protective effect of bilberry.
Our data show that cardiac levels of GSSG, MDA and PCC were significantly elevated, while those of GSH were significantly reduced following DOX administration as compared to the control group. Clearly, these data indicate the occurrence of oxidative stress, which is in accordance with reports of previous studies [32,33]. The reduced GSH and the elevated GSSG levels in the DOX group might be due to GSH consumption in the interactions of DOX-induced free radicals with bio-membrane and the subsequent lipid peroxidation. Pretreatment of rats with bilberry significantly guarded against the oxidative stress observed in the DOX group. Furthermore, the activity of the cardiac antioxidant enzymes CAT, SOD and GSH-Px were significantly reduced, while that of MPO was significantly elevated in response to DOX administration as compared to the control group. These data are in accord with those reported by many investigators [34,35]. Our results also indicate that bilberry alleviated the decrease of the activity of the antioxidant enzymes, and can be explained by its high content of several antioxidants including anthocyanine, flavonoids and phenolic acids [7]. These compounds were reported to inhibit oxidative processes in other tissues [36]. They have been shown to effectively scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide [37], improve the ferric-reducing antioxidant power in plasma [38] and suppress the DNA damage induced by DOX [39]. Moreover, Li et al. [31] reported that procyanidins from grape seeds protected rats from DOX-induced myocardial damage and cardiac dysfunction by scavenging the free radical. The increased MPO activity in the DOX group denotes leukocyte accumulation, with subsequent oxidative injury in cardiac tissue [40,41]. Despite the positive effects of flavonoids in experimental models of DOX cardiotoxicity, clinical trials have shown little success [42].
Conclusions
Regarding serum biochemical parameters, DOX significantly elevated serum LDH activity and CPK, CK-MB and troponin I levels; all of which indicate cardiac injury [43]. Similar observations were previously reported by Shi et al. [44] and Iqbal et al. [45]. Bilberry, in the present study, significantly inhibited DOX-induced elevations in serum activity of LDH, CPK and CK-MB, as well as troponin I levels. Histopathological examination showed cardiac injury in the DOX group in the form of cytoplasmic vacuole formation, interstitial edema and vascular degeneration, typically present in acute DOX-induced cardiotoxicity in rats [46,47] and mice [48]. The severity of the histological changes was much less in sections from rats pretreated with bilberry. According to the results of the present study, it can be concluded that bilberry protects against DOX-induced cardiotoxicity in rats, which can be attributed, at least in part, to its antioxidant activity.
References
1. Shan K, Lincoff AM, Young JB, Anthracycline-induced cardiotoxicity: Ann Intern Med, 1996; 125; 47-58, pmid: 8644988
2. Hortobagyi GN, Anthracyclines in the treatment of cancer. An overview: Drugs, 1997; 54; 1-7, pmid: 9361955
3. Myers C, Bonow R, Palmeri S, A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine: Semin Oncol, 1983; 10; 53-55, pmid: 6340204
4. Singal PK, Segstro RJ, Singh RP, Kutryk MJ, Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy: Can J Cardiol, 1985; 1; 139-47, pmid: 3931886
5. Singal PK, Deally CM, Weinberg LE, Subcellular effects of adriamycin in the heart: a concise review: J Mol Cell Cardiol, 1987; 19; 817-28, pmid: 3320376
6. Nazeyrollas P, Prévost A, Baccard N, Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity: Cancer Chemother Pharmacol, 1999; 43; 227-32, pmid: 9923553
7. Liu X, Chen Z, Chua CC, Melatonin as an effective protector against doxorubicin-induced cardiotoxicity: Am J Physiol Heart Circ Physiol, 2002; 283; H254-63, pmid: 12063298
8. Morton LW, Abu-Amsha Caccetta R, Puddey IB, Croft KD, Chemistry and biological effects of dietary phenolic compounds: Relevance to cardiovascular disease: Clin Exp Pharmacol Physiol, 2000; 27(3); 152-59, pmid: 10744340
9. Tapiero H, Tew KD, Ba GN, Mathé G, Polyphenols: Do they play a role in the prevention of human pathologies?: Biomed Pharmacother, 2002; 56(4); 200-7, pmid: 12109813
10. Devi A, Jolitha AB, Ishii N, Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats: Med Sci Monit, 2006; 12(4); 124-29
11. Heinonen M, Antioxidant activity and antimicrobial effect of berry phenolics – a finnish perspective: Mol Nutr Food Res, 2007; 51(6); 684-91, pmid: 17492800
12. Broneel M, Kozirog M, Duchnowicz P, Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker level in patients with metabolic syndrome: Med Sci Monit, 2010; 16(1); CR28-34, pmid: 20037491
13. Burdulis D, Sarkinas A, Jasutiené I: Acta Pol Pharm, 2009; 66(4); 399-408, pmid: 19702172
14. Elberry AA, Abdel-Naim AB, Abdel-Sattar EA: Food Chem Toxicol, 2010(48); 1178-84, pmid: 20146931
15. Fadillioglu E, Oztas E, Erdogan H, Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats: J Appl Toxicol, 2004; 24; 47-52, pmid: 14745846
16. Adams JD, Lauterburg BH, Mitchell JR, Plasma glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress: J Pharmacol Exp Ther, 1983; 227; 749-54, pmid: 6655568
17. Hissin PJ, Hilf RA, A fluorometric method for determination of oxidized and reduced glutathione in tissues: Anal Biochem, 1976; 74; 214-26, pmid: 962076
18. Uchiyama M, Mihara M, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test: Anal Biochem, 1978; 86; 271-78, pmid: 655387
19. Aebi H: Methods in Enzymology, 1984; 105; 121-26, New York, Academic Press
20. Sun Y, Oberley LW, Li Y, A simple method for clinical assay of superoxide dismutase: Clin Chem, 1988; 34; 497-500, pmid: 3349599
21. Paglia DE, Valentine WN, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase: J Lab Clin Med, 1967; 70; 158-69, pmid: 6066618
22. Wei H, Frenkel K: Carcinogenesis, 1993; 14; 1195-201, pmid: 8508507
23. Levine RL, Garland D, Oliver CN, Determination of carbonyl content in oxidatively modified proteins: Methods in Enzymology, V 186, Oxygen radicals in Biological Systems, 1990; 464-78, New York, Academic Press
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, Protein measurement with the Folin phenol reagent: J Biol Chem, 1951; 193; 265-75, pmid: 14907713
25. Singal PK, Iliskovic N, Doxorubicin-induced cardiomyopathy: N Engl J Med, 1998; 339; 900-5, pmid: 9744975
26. Franco F, Dubois SK, Peshock RM, Shohet RV, Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy: Am J Physiol Heart Circ Physiol, 1998; 274; H679-83
27. Takemura G, Fujiwara H, Doxorubicin-induced cardiomyopathy from Cardiotoxic mechanisms to management: Prog Cardiovasc Dis, 2007; 49; 330-52, pmid: 17329180
28. Šimùnek T, Štìrba M, Popelová O, Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron: Pharmacol Rep, 2009; 61; 154-71, pmid: 19307704
29. Larsen RL, Jakacki RI, Vetter VL, Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults: Am J Cardiol, 1992; 70; 73-77, pmid: 1615874
30. Puri A, Maulik SK, Ray R, Bhatnagar V, Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats: Eur J Pediatr Surg, 2005; 15; 387-91, pmid: 16418954
31. Li W, Xu B, Xu J, Wu XL, Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress: Basic Clin Pharmacol Toxicol, 2009; 104; 192-97, pmid: 19143757
32. Choi EH, Lee N, Kim HJ, Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes: Genes Nutr, 2008; 2; 337-45, pmid: 18850228
33. Ibrahim MA, Ashour OM, Ibrahim YF, Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity: Pharmacol Res, 2009; 60(5); 373-81, pmid: 19467331
34. Dbrowska K, Stuss M, Gromadzińska J, The effects of melatonin on glutathione peroxidase activity in serum and erythrocytes after adriamycin in normal and pinealectomised rats: Endokrynol Pol, 2008; 59(3); 200-6, pmid: 18615393
35. Tatlidede E, Sehirli O, Velioğlu-Oğünc A, Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage: Free Radic Res, 2009; 43; 195-205, pmid: 19169920
36. Ofek I, Goldhar J, Zafriri D, Anti-Escherichia coli adhesin activity of cranberry and blueberry juices: N Engl J Med, 1991; 324(22); 1599, pmid: 1674106
37. Chang WT, Shao ZH, Yin JJ, Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes: Eur J Pharmacol, 2007; 566; 58-66, pmid: 17475241
38. Busserolles J, Gueux E, Balasińska B: Int J Vitam Nutr Res, 2006; 76; 22-27, pmid: 16711653
39. de Rezende AA, Graf U, da Guterres ZR: Food Chem Toxicol, 2009; 47; 1466-72, pmid: 19341778
40. Riad A, Bien S, Westermann D, Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice: Cancer Res, 2009; 69(2); 695-99, pmid: 19147586
41. Arnhold J, Osipov AN, Spalteholz H, Effects of hypochlorous acid on unsaturated phosphatidylcholines: Free Radic Biol Med, 2001; 31(9); 1111-19, pmid: 11677044
42. Bruynzeel AME, Niessen HWM, Bronzwaer JGF, The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study: Br J Cancer, 2007; 97; 1084-89, pmid: 17940501
43. Herman E, Mhatre R, Lee IP, Comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys: Pharmacology, 1971; 6; 230-41, pmid: 5002849
44. Shi R, Liu L, Huo Y, Cheng YY: Zhongguo Zhong Yao Za Zhi, 2007; 32(24); 2632-35, pmid: 18338604
45. Iqbal M, Dubey K, Anwer T, Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats: Pharmacol Rep, 2008; 60(3); 382-90, pmid: 18622063
46. Morishima I, Matsui H, Mukawa H, Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats: Life Sci, 1998; 63; 511-21, pmid: 9718077
47. Mukherjee S, Banerjee SK, Maulik M, Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression: BMC Pharmacol, 2003; 3; 16, pmid: 14687418
48. Xin YF, Zhou GL, Shen M, Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity: Basic Clin Pharmacol Toxicol, 2007; 101; 421-26, pmid: 17971065
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






